| Product Code: ETC7645375 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Autoimmune Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Autoimmune Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Autoimmune Treatment Market - Industry Life Cycle |
3.4 Israel Autoimmune Treatment Market - Porter's Five Forces |
3.5 Israel Autoimmune Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Autoimmune Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Israel Autoimmune Treatment Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Israel Autoimmune Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Israel |
4.2.2 Growing awareness and diagnosis of autoimmune conditions |
4.2.3 Advancements in medical technology and treatment options for autoimmune diseases |
4.3 Market Restraints |
4.3.1 High cost of autoimmune treatments in Israel |
4.3.2 Limited accessibility to specialized healthcare services for autoimmune conditions |
4.3.3 Stringent regulatory requirements for approval of autoimmune treatment drugs |
5 Israel Autoimmune Treatment Market Trends |
6 Israel Autoimmune Treatment Market, By Types |
6.1 Israel Autoimmune Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Autoimmune Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Autoimmune Treatment Market Revenues & Volume, By Rheumatic Disease, 2021- 2031F |
6.1.4 Israel Autoimmune Treatment Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.5 Israel Autoimmune Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.6 Israel Autoimmune Treatment Market Revenues & Volume, By Inflammatory Bowel Disease, 2021- 2031F |
6.1.7 Israel Autoimmune Treatment Market Revenues & Volume, By Other Indications, 2021- 2031F |
6.2 Israel Autoimmune Treatment Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Autoimmune Treatment Market Revenues & Volume, By Anti-Inflammatory, 2021- 2031F |
6.2.3 Israel Autoimmune Treatment Market Revenues & Volume, By Anti-Hyperglycemics, 2021- 2031F |
6.2.4 Israel Autoimmune Treatment Market Revenues & Volume, By NSAIDs, 2021- 2031F |
6.2.5 Israel Autoimmune Treatment Market Revenues & Volume, By Interferons, 2021- 2031F |
6.2.6 Israel Autoimmune Treatment Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.3 Israel Autoimmune Treatment Market, By Sales Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Autoimmune Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Israel Autoimmune Treatment Market Revenues & Volume, By Online, 2021- 2031F |
6.3.4 Israel Autoimmune Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Autoimmune Treatment Market Import-Export Trade Statistics |
7.1 Israel Autoimmune Treatment Market Export to Major Countries |
7.2 Israel Autoimmune Treatment Market Imports from Major Countries |
8 Israel Autoimmune Treatment Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for autoimmune conditions |
8.2 Number of clinical trials for new autoimmune treatments conducted in Israel |
8.3 Patient adherence rates to prescribed autoimmune treatment regimens |
9 Israel Autoimmune Treatment Market - Opportunity Assessment |
9.1 Israel Autoimmune Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Autoimmune Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Israel Autoimmune Treatment Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Israel Autoimmune Treatment Market - Competitive Landscape |
10.1 Israel Autoimmune Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Autoimmune Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here